L-Dopa in the treatment of parkinsonism.
D000109:Acetylcholine / Q000502:physiology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001921:Brain / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007700:Kinetics; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D009638:Norepinephrine / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine